NCT05426200 Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
| NCT ID | NCT05426200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Lung Transplant |
| Study Type | INTERVENTIONAL |
| Enrollment | 230 participants |
| Start Date | 2023-01-25 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 230 participants in total. It began in 2023-01-25 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To examine the effectiveness of an individual health coaching intervention for lung transplant candidates. This intervention will include up to 12 health coaching sessions via phone call over a 12-16 week period. This will be compared to a usual care group the receives pre-transplant care and education alone.
Eligibility Criteria
Inclusion Criteria: * Waitlisted or deferred for lung transplantation at Mayo Clinic Rochester, Mayo Clinic Florida, or University of Washington Exclusion Criteria: * Under 18 years old * Non-English speaking, nonverbal, or extremely hard of hearing
Contact & Investigator
Cassie C Kennedy, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05426200 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05426200 currently recruiting?
Yes, NCT05426200 is actively recruiting participants. Contact the research team at kennedy.cassie@mayo.edu for enrollment information.
Where is the NCT05426200 trial being conducted?
This trial is being conducted at Jacksonville, United States, Rochester, United States, Seattle, United States.
Who is sponsoring the NCT05426200 clinical trial?
NCT05426200 is sponsored by Mayo Clinic. The principal investigator is Cassie C Kennedy, MD at Mayo Clinic. The trial plans to enroll 230 participants.